dalteparin has been researched along with Bacteremia in 9 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
Bacteremia: The presence of viable bacteria circulating in the blood. Fever, chills, tachycardia, and tachypnea are common acute manifestations of bacteremia. The majority of cases are seen in already hospitalized patients, most of whom have underlying diseases or procedures which render their bloodstreams susceptible to invasion.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Lemierre's syndrome is a potentially fatal disease that usually presents with oropharyngeal infection, followed by sepsis, thrombosis of the internal jugular vein and septic emboli." | 2.45 | Unusual presentation of Lemierre's syndrome: two cases and a review. ( Brandjes, DP; Gerdes, VE; Soesan, M; van Gorp, EC; van Wissen, M, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 5 (55.56) | 29.6817 |
| 2010's | 3 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| van Wissen, M | 1 |
| Gerdes, VE | 1 |
| van Gorp, EC | 1 |
| Brandjes, DP | 1 |
| Soesan, M | 1 |
| Ruiz-Valverde, MP | 1 |
| Barberà , JR | 1 |
| Segarra, A | 1 |
| Capdevila, JA | 1 |
| Evangelista, A | 1 |
| Piera, L | 1 |
| Peetermans, M | 1 |
| Liesenborghs, L | 1 |
| Peerlinck, K | 1 |
| Wijngaerden, EV | 1 |
| Gheysens, O | 1 |
| Goffin, KE | 1 |
| Hoylaerts, MF | 1 |
| Jacquemin, M | 1 |
| Verhaegen, J | 1 |
| Peetermans, WE | 1 |
| Verhamme, P | 1 |
| Vanassche, T | 1 |
| Pruitt, LG | 1 |
| Mosley, JC | 1 |
| Lasseigne, RF | 1 |
| Amezyane, T | 1 |
| Abouzahir, A | 1 |
| El Kharrass, A | 1 |
| Bassou, D | 1 |
| Fatihi, J | 1 |
| Hammi, S | 1 |
| Mahassin, F | 1 |
| Ghafir, D | 1 |
| Ohayon, V | 1 |
| Lai, TF | 1 |
| Wu, J | 1 |
| Henderson, T | 1 |
| Winlaw, W | 1 |
| Malcolm, SJ | 1 |
| Fasano, R | 1 |
| Kent, P | 1 |
| Valentino, L | 1 |
| Keller, JE | 1 |
| Hindman, JW | 1 |
| Mehall, JR | 1 |
| Smith, SD | 1 |
2 reviews available for dalteparin and Bacteremia
| Article | Year |
|---|---|
Unusual presentation of Lemierre's syndrome: two cases and a review.
Topics: Acenocoumarol; Anti-Bacterial Agents; Anticoagulants; Bacteremia; Deglutition Disorders; Diarrhea; F | 2009 |
Superior vena cava thrombus treated with low-dose, peripherally administered recombinant tissue plasminogen activator in a child: case report and review of the literature.
Topics: Anti-Bacterial Agents; Anticoagulants; Antineoplastic Combined Chemotherapy Protocols; Bacteremia; C | 2005 |
1 trial available for dalteparin and Bacteremia
| Article | Year |
|---|---|
Targeting Coagulase Activity in Staphylococcus aureus Bacteraemia: A Randomized Controlled Single-Centre Trial of Staphylothrombin Inhibition.
Topics: Administration, Intravenous; Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Antithro | 2018 |
6 other studies available for dalteparin and Bacteremia
| Article | Year |
|---|---|
Successful treatment of catheter-related sepsis and extraluminal catheter thrombosis with vancomycin and fraxiparin without catheter removal.
Topics: Adult; Anti-Bacterial Agents; Anticoagulants; Bacteremia; Catheterization, Central Venous; Catheters | 1997 |
Bacteremia and Deep Vein Thrombosis in an Infant.
Topics: Anti-Bacterial Agents; Anticoagulants; Bacteremia; Ceftriaxone; Clindamycin; Edema; Emergency Servic | 2016 |
[Septic pylephlebitis associated with Enterobacter cloacae septicemia].
Topics: Abdominal Pain; Adult; Anti-Bacterial Agents; Anticoagulants; Bacteremia; Ceftriaxone; Community-Acq | 2010 |
Septic superior ophthalmic vein thrombosis: to coagulate or not to coagulate?
Topics: Anticoagulants; Bacteremia; Enoxaparin; Humans; Orbit; Orbital Diseases; Staphylococcal Infections; | 2002 |
Septic superior ophthalmic vein thrombosis: enoxaparin needs to be monitored.
Topics: Anticoagulants; Bacteremia; Drug Monitoring; Enoxaparin; Humans; Orbit; Orbital Diseases; Staphyloco | 2002 |
Enoxaparin inhibits fibrin sheath formation and decreases central venous catheter colonization following bacteremic challenge.
Topics: Animals; Anticoagulants; Bacteremia; Catheterization, Central Venous; Catheters, Indwelling; Enoxapa | 2006 |